Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cohera Medical Inc.

Latest From Bausch & Lomb Inc.

Medtech Value Brands: Stepping Down May Boost The Top Line

The medtech industry has traditionally grown through innovation – new products with improved features and benefits have fueled revenue growth. However, innovation alone does not garner the price premium it once did, and manufacturers must decide whether to pursue a value brand strategy alongside their traditional premium brand, says global management consulting firm Simon-Kucher & Partners.

Pricing Strategies Business Strategies

Shire's Ornskov On Goals And Accomplishments One Year After Baxalta Merger

Shire's CEO says he sees scientific and technological advances as an opportunity to become the leading rare disease company. Ornskov also talked about the firm's debt-reduction and M&A strategy going forward.

Rare Diseases Companies

Valeant On Track With Debt-Reduction Goals, But Will It Be Enough?

The troubled firm has pushed back its greatest debt burden until 2020, but new products are unlikely to fill sales gap. Valeant says its GI unit is showing positive signs and that a restructuring of the derm commercial unit is nearing completion.

Sales & Earnings Financing

With Parion Deal Done, Shire CEO Looks To Next Bright Ophthalmic Innovation

Shire's CEO Flemming Ornskov says he's focused on the specialist pharma's emerging ophthalmics division - and open to fresh innovative collaborations like that signed this week with Parion Sciences.

Deals Rare Diseases
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Surgical Equipment & Devices
      • Surgical Sealants
  • Therapeutic Areas
  • Wound Healing & Tissue Repair
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cohera Medical Inc.
  • Senior Management
  • Patrick Daly, Pres. & CEO
    Richard L Wonsettler, VP, Fin. & CFO
    Dottie Clower, PhD, CSO
  • Contact Info
  • Cohera Medical Inc.
    Phone: (412) 231-1500
    209 Sandusky St.
    Pittsburgh, PA 15212